Finance

Lists
PER:ASX
Percheron Therapeutics Ltd
A$0.0040
-11.11%
(-0.00050) 1D
Sep 9, 10:06:34 AM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for PER...
Mkt. cap
8.20M
Avg. vol.
4.40M
Volume
0.00
52-wk high
A$0.01
52-wk low
A$0.00
EPS
-A$0.00
Shares outstanding
1.82B
No. of employees
8
Mkt. cap
8.20M
Avg. vol.
4.40M
Volume
0.00
52-wk high
A$0.01
52-wk low
A$0.00
EPS
-A$0.00
Shares outstanding
1.82B
No. of employees
8
About Percheron Therapeutics Ltd
CEOJames Garner
Employees8
Founded2000
HeadquartersToorak, Victoria, Australia
SectorPharmaceutical industry
Websitepercherontx.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
44.20K
44.20K
377.60K
377.60K
Cost of goods sold
58.63K
58.63K
31.06K
31.06K
Cost of revenue
58.63K
58.63K
31.06K
31.06K
Research and development expenses
671.18K
671.18K
372.60K
372.60K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
732.56K
732.56K
657.51K
657.51K
Operating expense
1.53M
1.53M
1.19M
1.19M
Total operating expenses
1.59M
1.59M
1.22M
1.22M
Operating income
-1.55M
-1.55M
-840.64K
-840.64K
Other non operating income
-
-
-
-
EBT including unusual items
-1.55M
-1.55M
-843.02K
-843.02K
EBT excluding unusual items
-1.55M
-1.55M
-843.02K
-843.02K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.55M
-1.55M
-843.02K
-843.02K
Net profit margin
-3,512.84%
-3,512.84%
-223.26%
-223.26%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-5.29K
-5.29K
-2.38K
-2.38K
Net interest expenses
-5.29K
-5.29K
-2.38K
-2.38K
Depreciation and amortization charges
9.56K
9.56K
100.22K
100.22K
EBITDA
-1.54M
-1.54M
-740.42K
-740.42K
Gain or loss from assets sale
-
-
20.00
20.00
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps